Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
51%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
42%
ALSO IN MEDX
MEDX
28
HOLDINGS
36%
ALSO IN PPH
SECTOR DRIFT (PPH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 24.7% | 17.9% | 17.9% |
 |
NOVARTIS AG-ADR | 8.7% | 6.2% | 6.2% |
|
JOHNSON & JOHNSON | 4.6% | 4.9% | 4.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.5% | 5.3% | 4.5% |
|
ABBVIE INC | 4.2% | 8.7% | 4.2% |
PPH Overweight Relative to MEDX
|
ELI LILLY & CO | 6.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 6.0% |
|
MCKESSON CORP | 4.9% |
|
MERCK & CO. INC. | 4.7% |
 |
SANOFI-AVENTIS-ADR | 4.1% |
|
CENCORA INC | 3.8% |
|
ZOETIS INC | 3.3% |
|
NOVARTIS AG-ADR | 2.5% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.3% |
 |
TEVA PHARMACEUTICAL-SP ADR | 2.1% |
PPH Underweight Relative to MEDX
|
ALNYLAM PHARMACEUTICALS INC | -5.5% |
|
IONIS PHARMACEUTICALS, INC. | -5.1% |
|
ABBVIE INC | -4.5% |
|
AMGEN INC | -4.0% |
 |
ALKERMES PLC | -3.4% |
|
BIOGEN IDEC INC | -2.8% |
|
CRISPR THERAPEUTICS AG | -2.8% |
|
REGENERON PHARMACEUTICALS | -2.8% |
|
GALECTIN THERAPEUTICS INC | -1.5% |
|
BEAM THERAPEUTICS, INC. | -1.2% |